Cambridge Investment Research Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-554
| Closed | -$214K | – | 3271 |
|
|
2022
Q4 | $214K | Buy |
554
+7
| +1% | +$2.7K | ﹤0.01% | 2703 |
|
|
2022
Q3 | $184K | Buy |
547
+8
| +1% | +$2.69K | ﹤0.01% | 2723 |
|
|
2022
Q2 | $177K | Sell |
539
-20
| -4% | -$6.57K | ﹤0.01% | 2752 |
|
|
2022
Q1 | $245K | Buy |
559
+69
| +14% | +$30.2K | ﹤0.01% | 2717 |
|
|
2021
Q4 | $215K | Buy |
490
+7
| +1% | +$3.07K | ﹤0.01% | 2836 |
|
|
2021
Q3 | $269K | Buy |
483
+93
| +24% | +$51.8K | ﹤0.01% | 2550 |
|
|
2021
Q2 | $201K | Buy |
390
+20
| +5% | +$10.3K | ﹤0.01% | 2838 |
|
|
2021
Q1 | $289K | Buy |
370
+81
| +28% | +$63.3K | ﹤0.01% | 2312 |
|
|
2020
Q4 | $158K | Buy |
+289
| New | +$158K | ﹤0.01% | 2530 |
|
|
2020
Q3 | – | Sell |
-280
| Closed | -$172K | – | 2611 |
|
|
2020
Q2 | $172K | Sell |
280
-5
| -2% | -$3.07K | ﹤0.01% | 2205 |
|
|
2020
Q1 | $136K | Sell |
285
-55
| -16% | -$26.2K | ﹤0.01% | 2053 |
|
|
2019
Q4 | $197K | Sell |
340
-19
| -5% | -$11K | ﹤0.01% | 2219 |
|
|
2019
Q3 | $237K | Sell |
359
-193
| -35% | -$127K | ﹤0.01% | 1998 |
|
|
2019
Q2 | $428K | Sell |
552
-237
| -30% | -$184K | ﹤0.01% | 1532 |
|
|
2019
Q1 | $558K | Sell |
789
-5
| -0.6% | -$3.54K | 0.01% | 1411 |
|
|
2018
Q4 | $372K | Buy |
794
+59
| +8% | +$27.6K | ﹤0.01% | 1508 |
|
|
2018
Q3 | $634K | Buy |
735
+157
| +27% | +$135K | 0.01% | 1307 |
|
|
2018
Q2 | $398K | Buy |
578
+13
| +2% | +$8.95K | ﹤0.01% | 1541 |
|
|
2018
Q1 | $252K | Buy |
565
+23
| +4% | +$10.3K | ﹤0.01% | 1802 |
|
|
2017
Q4 | $239K | Sell |
542
-38
| -7% | -$16.8K | ﹤0.01% | 1801 |
|
|
2017
Q3 | $286K | Buy |
580
+60
| +12% | +$29.6K | ﹤0.01% | 1577 |
|
|
2017
Q2 | $288K | Buy |
520
+192
| +59% | +$106K | ﹤0.01% | 1531 |
|
|
2017
Q1 | $217K | Buy |
328
+1
| +0.3% | +$662 | ﹤0.01% | 1566 |
|
|
2016
Q4 | $109K | Buy |
327
+41
| +14% | +$13.7K | ﹤0.01% | 1584 |
|
|
2016
Q3 | $86K | Buy |
+286
| New | +$86K | ﹤0.01% | 1679 |
|